BNO
Click for more information
5.26% 20.0¢ bionomics limited

Ann: BNC105 Clinical Trial In Combination With Nivolumab, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. doubledeckerdog
    707 Posts.
    lightbulb Created with Sketch. 78
    clock Created with Sketch.
    09/01/19
    19:11
    Post #: 37072591
    BNO has been trying to flog this molecule for about five years - this trial is a last gasp attempt to spin a story about a doubtful drug candidate. Prepare to be disappointed!!! The Board is desperately trying to buy time, hoping for a miracle - again!

    GLTA - DYOR
    BNO Price at posting: 12.5¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM and Indium form strategic collaboration for recovering Gallium and Germanium
right-arrow Created with Sketch.
MKG Encouraging results for Raiden as Pegmatite extensions confirmed
right-arrow Created with Sketch.
NEWS Experienced CEO appointed to Indiana Resources
right-arrow Created with Sketch.
NEWS High grade drill results discovered at CODA North
right-arrow Created with Sketch.
NEWS Share Purchase Plan by robotic technology company now complete
right-arrow Created with Sketch.
NEWS Significant milestone reached in Zimbabwe's oil and gas exploration industry as Invictus Energy moves closer to execution
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.